Every material Form 8-K Legence Corp. has filed with the SEC since June 11, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Legence Corp. increased its board from six to seven directors and appointed Robert Crisci as a Class II director effective August 18, 2026. Crisci also joins the Audit Committee and the Nomination and Corporate Governance Committee, and the board determined he is independent under Nasdaq rules.
Crisci, age 51, previously served as CFO of Lineage, Inc. from 2023 until retiring in November 2025, and as CFO of Roper Technologies from 2017 until January 2023.
He receives standard non-management director pay: an $85,000 annual cash retainer and restricted stock units valued at approximately $150,000 at grant.
His initial term expires at the 2027 annual meeting of shareholders, and he has signed the standard indemnification agreement (Exhibit 10.1).
Legence Corp. reported record second-quarter 2026 revenue of $1.26 billion, up 110.7% from a year earlier, and raised its full-year 2026 revenue and Adjusted EBITDA guidance. The company still posted a net loss attributable to Legence of $27.8 million, or $0.37 per diluted share, after $41.1 million in goodwill and long-lived asset impairments, and its gross margin fell to 17.4% from 21.5%. For shareholders, the filing shows strong top-line growth and higher outlook alongside a wider GAAP loss and lower margins.
Net loss attributable to Legence was $27.8 million, or $0.37 per diluted share, compared with a net loss of $5.3 million in the second quarter of 2025.
Non-GAAP Adjusted EBITDA was $154.6 million, up 114.1% from $72.2 million a year earlier.
Goodwill impairment of $21.6 million and long-lived asset impairment of $19.5 million were recorded in the quarter.
Full-year 2026 revenue guidance was raised to $4.7 billion to $4.8 billion from $4.1 billion to $4.3 billion, and Adjusted EBITDA guidance to $565 million to $585 million from $470 million to $490 million.
At its June 11, 2026 annual meeting, Legence Corp.'s stockholders approved a 2026 Employee Stock Purchase Plan, elected two Class I directors, and approved advisory pay and auditor proposals. The plan authorizes up to 1,580,053 Class A shares for employee purchases at a discount, which could add to the share count over time, subject to adjustment for certain corporate events.
Stockholders approved the 2026 Employee Stock Purchase Plan, authorizing up to 1,580,053 Class A shares, with 98,024,042 votes for and 4,856 against.
David Coghlan and Bilal Khan were elected Class I directors, with terms running until the 2029 annual meeting.
Stockholders approved 2026 named executive officer compensation on an advisory basis, with 95,847,463 votes for and 2,119,206 against.
Stockholders chose an annual frequency for future advisory votes on executive compensation, and Deloitte & Touche LLP was ratified as auditor for fiscal 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Legence Corp. filing is on SEC EDGAR ↗. 8-K briefs of other companies →